The global landscape of medicine is shifting. We are moving away from broad-spectrum treatments and toward precision-engineered biological interventions. At the heart of this revolution lies the Viral ...

Eagle Point Credit and other CLO equity CEFs suffered recent price declines, but NAV returns remain broadly consistent with ...

Is it really that simple?

The mission-critical communication market presents opportunities through increasing private LTE deployments, AI adoption for ...

Treatment Phase for Lead Clinical Candidate PH-762 Dose Escalation Trial is Complete with Favorable Safety, Tolerability and ...